STUDY QUESTION: Does the chemosensory activation of CatSper Ca 2+ channels in human sperm give rise to additive, sub-additive or even synergistic actions among agonists?
Introduction
Male fertility disorders are common and their cause is often unknown , but exposure to endocrine disrupting chemicals (EDCs) is suspected to be involved (Gore et al., 2015) . EDCs are usually examined in studies aiming to elucidate the action of single substances on organisms, organs, tissues, cells or particular proteins, whereas the quantitative analysis of combined EDC actions has received less attention (Kortenkamp, 2014) . In daily life, however, humans are exposed to a plethora of EDCs originating from a broad range of sources. Therefore, human body fluids are contaminated with complex mixtures of EDCs (Kortenkamp, 2014 ) that act via multiple binding sites and mechanisms. This might create not only additive and sub-additive but also synergistic actions among the chemicals. A prime example for combined EDC actions is human sperm: at concentrations present in human body fluids, structurally diverse EDCs activate the sperm-specific Ca 2+ channel CatSper (Tavares et al., 2013; Schiffer et al., 2014; Rehfeld et al., 2016) that is essential for sperm function and male fertility (Williams et al., 2015) . Thereby, the chemicals interfere with various sperm functions (Tavares et al., 2013; Schiffer et al., 2014; Rehfeld et al., 2016) . In fact, EDCs mimic the action of the oviductal CatSper ligands progesterone and prostaglandins (Schiffer et al., 2014; Rehfeld et al., 2016) that act via a steroid-and prostaglandinbinding site, respectively, to activate the channel (Lishko et al., 2011; Strünker et al., 2011) . It has been proposed that progesterone binds to the receptor alpha/beta hydrolase domain-containing protein 2 (ABHD2) (Miller et al., 2016) : at rest, CatSper is inhibited by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the flagellar membrane. Upon progesterone binding, ABHD2 degrades 2-AG and, thereby, relieves CatSper from inhibition (Miller et al., 2016) . CatSper activation by prostaglandins, however, does not involve ABHD2 (Miller et al., 2016) but an as yet unknown receptor. Progesterone-and prostaglandin-induced Ca 2+ influx has been implicated in sperm capacitation (Sumigama et al., 2015) , chemotaxis (Eisenbach and Giojalas, 2006; Publicover et al., 2008) , hyperactivation (Alasmari et al., 2013a (Alasmari et al., , 2013b Rennhack et al., 2018) and acrosomal exocytosis (Tamburrino et al., 2014; Rennhack et al., 2018) . Individual EDCs compete either with progesterone or prostaglandins to activate CatSper and, thereby, desensitize sperm for the respective physiological ligand (Schiffer et al., 2014; Rehfeld et al., 2016) . Notably, when applied in complex lowdose mixtures, EDCs seem to co-operate to elevate Ca 2+ levels in human sperm (Schiffer et al., 2014; Rehfeld et al., 2016) . Thus, human sperm can serve as a model to elucidate the action of EDC mixtures in mechanistic terms. To this end, we investigated the combined action of progesterone and prostaglandins as well as that of the EDCs benzylidene camphor sulfonic acid (BCSA) and α-Zearalenol in sperm.
BCSA and α-Zearalenol act via the steroid-and prostaglandin-binding site, respectively (Schiffer et al., 2014; Rehfeld et al., 2016) .
Materials and Methods

Reagents
BCSA was obtained from Life Chemicals (Munich, Germany). 
Semen samples
Human semen samples were obtained from healthy donors with their prior written consent. Semen samples were produced by masturbation and ejaculated into plastic containers. After ejaculation, the samples were allowed to liquefy for 15-30 min at 37°C.
Ethical approval
Approval was obtained from the ethical committees of the medical association Westfalen-Lippe and the medical faculty of the University of Münster: 4INie.
Purification of motile sperm cells via swim-up
Motile spermatozoa were isolated from the ejaculates by swim-up separation for 1 h at 37°C in human tubular fluid (HTF) medium containing (all mM): 97.8 NaCl, 4.69 KCl, 0.2 MgSO 4 , 0.37 KH 2 PO 4 , 2.04 CaCl 2 , 0.33 Na-pyruvate, 21.4 Na-lactate, 2.78 glucose, 21 HEPES, and 4 NaHCO 3 , adjusted to pH 7.3-7.4 with NaOH, as described before (Strünker et al., 2011) . The sperm were washed two times (700g, 20 min, room temperature) and the sperm concentration was adjusted to 1 × 10 7 /ml in HTF fortified with human serum albumin (3 mg/ml) (HTF + ).
Measurement of changes in [Ca
2+
] i
Changes in [Ca 2+ ] i were measured in 384 multi-well plates in a fluorescence plate reader (FLUOstar Omega, BMG Labtech, Germany) at 30°C, as described previously (Schiffer et al., 2014) . Sperm were loaded with the fluorescent Ca 2+ indicator Fluo-4FF-AM, Fluo-4-AM or Mag-Fluo-4-AM (10 μM) for 45 min at 37°C. After incubation, excess dye was removed by centrifugation (700g, 10 min, room temperature). Sperm were resuspended in HTF at a concentration of 5 × 10 6 /ml. Each well was filled with 50 μl of the sperm suspension. Fluorescence was excited at 485 nm and emission was recorded at 520 nm with bottom optics. Fluorescence was recorded before and after injection of 25 μl of serially diluted ligands and ligand mixtures, of buffer with vehicle (negative control), and of a reference (progesterone 10 μM, PGE1 5 μM, and NH 4 Cl 30 mM, in the experiments with Fluo-4FF and mag-Fluo-4; ionomycin 5 μM for experiments with Fluo-4) to determine the response to a [Ca 2+ ] i increase that saturates the indicator. The ligands, mixtures thereof, and controls were injected simultaneously using a multichannel pipette. Each condition was measured in duplicate and the two fluorescence traces were averaged. To determine the doseresponse relations, the signal amplitudes were normalized to the reference and fitted (nonlinear, least squares) using a modified Hill equation:
n n n , with y being the effect of the ligand at concentration x, Vmax the maximal response amplitude, k the K 1/2 value and n the Hill coefficient of the fit.
Electrophysiology
We recorded from sperm in the whole-cell configuration, as described before (Strünker et al., 2011) . Seals between pipette and sperm were formed either at the cytoplasmic droplet or in the neck region in standard extracellular solution containing (all mM): 135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl 2 , 5 glucose, 1 Na-pyruvate, 10 lactic acid, 20 HEPES, adjusted to pH 7.4 with NaOH. Monovalent currents were recorded in a sodium-based divalent-free solution (NaDVF) containing (all mM): 140 NaCl, 40 HEPES, and 1 EGTA, adjusted to pH 7.4 with NaOH; the pipette (10-15 MΩ) solution contained (all mM): 130 Cs-aspartate, 50 HEPES, 5 EGTA, 5 CsCl, adjusted to pH 7.3 with CsOH. Data were not corrected for liquid junction potentials.
Analysis of synergism
We employed curve-shift analysis (Zhao et al., 2010) , curvilinear isobolographic analysis (Grabovsky and Tallarida, 2004) , and the combinationindex method (Chou and Talalay, 1984) to assess the nature of the combined action of the ligands.
For the curve-shift analysis, we modeled for the mixtures of two ligands the responses that are expected if the ligands act in a purely additive manner. To predict the additive response of a given mixture, we extrapolated the response evoked by the given concentration (a) of the less efficacious ligand A on its own and determined the so called equivalent concentration (b eq ) of the more efficacious ligand B evoking that particular response, using the Vmax, k and n of the individual dose-response relations for ligand A and B and the formula provided by Grabovsky and Tallarida (2004) : Curvilinear isobolographic analysis (Grabovsky and Tallarida, 2004) : the curvilinear isoboles indicate all possible mixtures of two ligands expected to evoke a given response level if the ligands act purely in an additive manner, plotted in a diagram that depicts the respective concentrations of the more effective ligand B (b) and the less effective ligand A (a) on the y-and x-axis, respectively. The isobole for a given relative response level (y) was calculated as a function of (a) with the following formula:
with b y being the concentration of the more efficacious ligand B evoking that response level on its own, and b eq (a) representing the concentration of ligand B equivalent to (a), calculated according to Equation (1). This analysis was performed for relative response levels up to the maximal level evoked by the more efficacious ligand B. For a given response level, the experimentally determined ligand mixture evoking that particular response level is plotted in the diagram. A superimposition of the experimentally determined mixtures on the respective isobole indicates additivity, whereas mixtures plotting below or above the isobole indicate synergism and sub-additivity, respectively.
The combination index (Chou and Talalay, 1984) was calculated using the effective concentrations (EC) evoking a particular relative response level, i.e. the concentration evoking 10% of the maximal response (EC10), 20% (EC20), 30% (EC30), etc., extrapolated from the dose-response relations for the individual ligands and the mixtures thereof with the following formula:
, with CI being the combination index, ECx mixA and ECx mixB the concentrations of ligand A and B in a given mixture evoking x% of the maximal relative response level, and ECx A and ECx B being the concentrations of ligand A and B that evoke that response level on their own. This analysis was used for relative response levels up to the maximal response level reached by both ligands. A CI = 1 indicates an additive action, a CI > 1 indicates sub-additivity, whereas a CI < 1 indicates synergism.
Data analysis
All data are presented as mean ± SD. Data analysis and fitting of doseresponse relations were performed using Origin 2015 (OriginLab, Northampton, MA, USA). (Fig. 1A, B) ; as a reference, to gauge the maximal response level, we recorded a Ca 2+ response that saturated the indicator.
Results
Synergistic activation of human CatSper by progesterone and PGE1
Analysis of the normalized dose-response relations yielded constants of half-maximal activation (K 1/2 ) of 101 ± 113 nM (n = 24) for progesterone and 28 ± 13 nM for PGE1 (n = 18) (Fig. 1D ). The amplitudes of the progesterone-and PGE1-induced Ca 2+ signals saturated at relative response levels of 0.76 ± 0.1 (n = 24) and 0.49 ± 0.1 (n = 18), respectively (Fig. 1D) . Thus, PGE1 is more potent but less efficacious than progesterone to evoke Ca 2+ responses in human sperm. Next, we studied the Ca 2+ signals evoked by 2:1 mixtures of progesterone and PGE1. Similar to the individual ligands, the mixtures evoked a rapid and dose-dependent Ca 2+ transient (Fig. 1C) . The nature of the combined action of the ligands was evaluated by curve-shift analysis (Zhao et al., 2010) . The analysis of combined drug actions relies on the dose equivalence principle, also referred to as Loewe Additivity (Loewe and Muischnek, 1926) . Quite general, from the individual dose-response relationships of progesterone and PGE1, one can determine for any concentration of PGE1 the equivalent concentration of progesterone evoking the same response level. Therefore, if progesterone and PGE1 acted purely additively, the response level evoked by a particular progesterone/PGE1 mixture could be predicted by transforming the PGE1 concentration in the mixture into the equivalent progesterone concentration. Accordingly, we modeled the dose-response relation for the 2:1 progesterone/PGE1 mixtures that is expected for a purely additive action (Fig. 1E, black) and compared it to the experimentally determined dose-response relation (Fig. 1E, red) . The experimental relation saturated at a considerably higher response level (0.94 ± 0.08 versus 0.78 ± 0.05; n = 5) and was left-shifted towards lower ligand concentrations. For a given response level, we calculated the ratio [Prog + PGE1] exp /[Prog + PGE1] pred between the progesterone (Prog) and PGE1 concentration in a given mixture extrapolated from the experimentally determined dose-response relation and the progesterone and PGE1 concentration predicted by the modeled additive dose-response relation to reach that particular response level. For an additive action, this ratio is 1, whereas a ratio >1 and <1 indicates sub-additivity and synergism, respectively. At response levels ≥0.1, the ratio was less than 1 and it decreased with increasing response levels, i.e. higher ligand concentrations in the mixture, from 0.59 ± 0.29 to 0.02 ± 0.04 (n = 5) at response levels of 0.1 and 0.7, respectively (Fig. 1F) . Altogether, these results indicate that progesterone and PGE1 activate CatSper synergistically and that the synergism is enhanced at high compared to low ligand concentrations. Of note, progesterone and PGE1 also acted synergistically in 1:1 or 1:2 mixtures ( Supplementary Fig. S1 ). Furthermore, we studied the Ca 2+ responses evoked by mixtures of ligands that compete for the same binding site to activate CatSper -competitive ligands cannot act synergistically (Chou and Talalay, 1984) . Indeed, for mixtures of progesterone and progesterone-3-(O-carboxymethyl)oxime (CMO-progesterone) (Fig. 1G , H, Supplementary Fig. S2 ) or of PGE1 and PGF1-α ( Fig. 1I, J ; Supplementary Fig. S2 ), the experimentally determined dose-response relations superimposed on that predicted for a purely additive action. Consequently, at all response levels, the ratio [Prog
was ≥1 (Fig. 1F) . Moreover, in addition to the curve-shift analysis, we employed isobolographic analysis (Grabovsky and Tallarida, 2004) ( Supplementary Fig. S3 A-C, E) and the combination-index method (Chou and Talalay, 1984) (Supplementary Fig. S3F ) to study the action of the mixtures. These methods confirmed that progesterone and PGE1, but not derivatives of progesterone or prostaglandins, act synergistically to increase [Ca 2+ ] i in human sperm. Of note, to unveil this synergistic ligand action, a medium-to low-affinity Ca 2+ indicator is required, e.g. Fluo-4FF or magFluo-4 (KD = 22 μM) ( Supplementary Fig. S4 ): the common high-affinity indicator Fluo-4 (KD = 335 nM) already becomes saturated with Ca 2+ during the responses evoked by progesterone and PGE1 alone (Supplementary Fig. S4 ). This masks not only the enhanced efficacy of progesterone compared to PGE1, but also the synergistic action of the ligands (Supplementary Fig. S4 ).
To scrutinize the synergistic action of progesterone and PGE1 by an independent technique, we recorded CatSper currents in human sperm by whole-cell patch clamping ( Fig. 2A-C) . The amplitude of monovalent CatSper currents at −80 mV was −9.9 ± 2.8 pA (Fig. 2C,  control) ; superfusion of sperm with a saturating (1 μM) concentration of progesterone or PGE1 increased the current amplitudes to −85 ± 60 and −38 ± 24 pA ( Fig. 2A-C) , respectively, reflecting the more efficacious activation of CatSper by progesterone compared to PGE1. Moreover, superfusion of sperm with a progesterone/PGE1 mixture (1 μM/1 μM) increased the amplitude to −357 ± 40 pA ( Fig. 2A-C) , which exceeds the amplitude expected for a purely additive action (~−124 pA) by about threefold. Altogether, these data clearly show that the oviductal ligands progesterone and PGE1 synergistically activate CatSper in human sperm.
Synergistic activation of human CatSper by EDCs
Finally, we studied the combined action of EDCs. Human CatSper is activated by structurally diverse EDCs that mimic the action of the oviductal ligands (Tavares et al., 2013; Schiffer et al., 2014; Rehfeld et al., 2016) . Prime examples of EDCs that activate CatSper are the UV filter BCSA and the growth promoter α-Zearalenol that act via the steroidand prostaglandin-binding site, respectively (Schiffer et al., 2014; Rehfeld et al., 2016) . BCSA and α-Zearalenol alone evoked a transient and dose-dependent Ca 2+ increase (Fig. 3A, B) that was suppressed by the CatSper inhibitor RU1968 (Rennhack et al., 2018) ( Supplementary Fig. S5 ), reinforcing that the chemicals act via CatSper. Analysis of the normalized dose-response relation yielded K 1/2 values of 19.9 ± 7.5 μM for BCSA and 2.2 ± 0.8 μM for α-Zearalenol (n = 6) ( Fig. 3D) . Moreover, the Ca 2+ amplitudes saturated at response levels of 0.75 ± 0.08 and 0.33 ± 0.13, respectively (n = 6) (Fig. 3D) . Thus, α-Zearalenol is more potent but less efficacious than BCSA to activate CatSper. Next, we tested the action of 2:1 mixtures of BCSA and α-Zearalenol. Similar to the individual ligands, the mixtures evoked a rapid and dose-dependent Ca 2+ transient (Fig. 3C) . Compared to the predicted additive dose-response relation, the experimentally determined dose-response relation was left-shifted to lower ligand concentrations, but settled at a similar maximal response level (Fig. 3E) ; at response levels ≥0.1, the ratio [BCSA + α-Zearalenol] exp /[BCSA + α-Zearalenol] pred was less than 1 and decreased with increasing response levels (Fig. 3F) . At a level of 0.1 and 0.7, the ratio was 0.83 ± 0.22 and 0.17 ± 0.06 (n = 6) ( Fig. 3F) , respectively. These results demonstrate that BCSA and α-Zearalenol act synergistically in human sperm and that the synergism is enhanced at high versus low concentrations of the chemicals; isobolographic analysis ( Supplementary Fig. S3D , E) and the combination-index method ( Supplementary Fig. S3F ) yielded similar results. Yet, the synergism between the EDCs is not as pronounced as that between progesterone and PGE1: over the entire range of response levels, the experimental/predicted concentration ratio was less for the mixtures of physiological ligands than for that of the EDCs (Fig. 3H) . Finally, we examined the action of mixtures of progesterone and α-Zearalenol. Compared to the predicted additive dose-response relation, the experimentally determined dose-response relation was left-shifted to lower ligand concentrations, indicating that also progesterone and α-Zearalenol act synergistically in human sperm (Fig. 3F, G ).
Discussion
Mutations in CATSPER genes (Avidan et al., 2003; Avenarius et al., 2009; Zhang et al., 2007; Hildebrand et al., 2010; Smith et al., 2013; Jaiswal et al., 2014) and CatSper dysfunction (Williams et al., 2015) are associated with male infertility in humans, indicating that CatSper represents a central signaling node in human sperm. In fact, CatSper serves as a polymodal sensor, integrating diverse chemical and physical cues (Brenker et al., 2012; Miki and Clapham, 2013 ) that assist sperm for fertilization. Progesterone and prostaglandins have been proposed to guide sperm to the egg (Eisenbach and Giojalas, 2006; Publicover et al., 2008) and to facilitate the penetration of its vestments (Schaefer et al., 1998; Tamburrino et al., 2014) . However, the role of these hormones during fertilization has not been definitely established (Baldi et al., 2009) , not least due to the challenge of experimentally emulating the complex chemical, topographical, and hydrodynamic landscapes of the female genital tract (Suarez and Pacey, 2006; Suarez, 2008; Kirkman-Brown and Smith, 2011; Miki and Clapham, 2013) . The results presented here underscore that fertilization is orchestrated by a complex interplay of various chemical cues. Progesterone and prostaglandins are released by cells lining the oviduct (Ogra et al., 1974; Vastik-Fernandez et al., 1975; Libersky and Boatman, 1995) and the cumulus cells surrounding the oocyte (Schuetz and Dubin, 1981) . The concentrations of these hormones in the oviduct are in the nanomolar range (Ogra et al., 1974; Libersky and Boatman, 1995; Munuce et al., 2006; Lamy et al., 2016) , whereas micromolar progesterone concentrations prevail within the cumulus oophorous (Osman et al., 1989) ; the concentration of prostaglandins within the cumulus oophorous is unknown. Thus, throughout their journey across the oviduct, until fusion with the oocyte, sperm are exposed to steroids and prostaglandins at the same time. Yet, previous studies have examined the action of these ligands independent of each other. Here, we show that, in fact, steroids and prostaglandins activate CatSper in a strongly synergistic fashion and, thereby, elevate [Ca 2+ ] i to levels that are not reached by each ligand alone. Future studies have to take this synergism into account: it needs to be addressed how the combined action of steroids and prostaglandins affects human sperm functions, such as the swimming behavior and acrosomal exocytosis. This might provide further insight into the ligand control of sperm behavior during fertilization. CatSper is also controlled by the membrane potential (V m ) and the intracellular pH (pH i ). However, the interplay between V m , pH i , and ligands to control CatSper during fertilization is unknown. Previous studies indicated that EDCs in reproductive fluids might disturb the precisely coordinated sequence of events underlying fertilization (Tavares et al., 2013; Schiffer et al., 2014; Rehfeld et al., 2016) . Activation of CatSper by these chemicals could evoke motility responses and the acrosome reaction at the wrong time and place (Tavares et al., 2013; Schiffer et al., 2014) . Furthermore, the desensitization of sperm to progesterone and prostaglandins (Schiffer et al., 2014; Rehfeld et al., 2016) might lead sperm astray on their way to the egg and could hamper the penetration of its vestments. Here, we demonstrate that the EDCs BCSA and α-Zearalenol synergistically activate Ca 2+ influx via CatSper in human sperm. This finding suggests that even low-dose EDC mixtures in reproductive fluids might affect human sperm in vivo, reinforcing concerns regarding the negative impact of EDCs on male reproductive health. The concentrations of EDCs, including BCSA and α-Zearalenol, in reproductive fluids are largely unknown. Therefore, to strengthen and extend our conclusions, more data concerning the molecular identities and concentrations of EDCs in seminal and oviductal fluids are required. In particular, studies using animal models, for example non-human primates, are required to scrutinize whether EDCs indeed disturb the fertilization process. Nevertheless, our data challenge the common risk-assessment strategy for EDCs: based on the NOAEL standard, safety thresholds are set for individual EDCs. Our findings demonstrate that this standard procedure is prone to underestimate the risk of adverse health effects, because synergistic actions among EDCs are not taken into account (Kortenkamp, 2014) . Supporting this notion, synergistic actions of EDCs were also observed in studies performed in human cell lines in vitro (Kim et al., 2005; Delfosse et al., 2015; Gan et al., 2015) and hepatocytes (Delfosse et al., 2015) as well on purified pregnane X receptors (Delfosse et al., 2015) . Altogether, this highlights the need to implement concepts for risk assessments that account for the combined action of chemicals.
Supplementary data
Supplementary data are available at Human Reproduction online.
